The NHS England and Improvement national patient safety alert (NatPSA) has specified a number of actions that organisations need to implement.
- To support implementation, the Society for Endocrinology, the Specialist Pharmacy Service (SPS), and the British Association of Dermatology (BAD) have produced more detailed guidance.
- This can be used by primary and secondary care providers as necessary to implement the NatPSA in a more consistent way.
The guidance addresses the following clinical questions
- Which patients are at risk of HPA axis suppression from exogenous steroids
- Who should be issued with a Steroid Emergency Card and have sick day rules
- Advice for intercurrent illness, procedures and surgery
- Who should have steroid cover for procedures, surgery and acute intercurrent illness
- Who requires adrenal function assessment
The link below may be disseminated as appropriate. Any queries from a pharmacy perspective please contact firstname.lastname@example.org
- fixed broken link